image
Intellia Therapeutics, Inc. NTLA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.29
-14.1 %
$ 755 M
Market Cap
-1.38
P/E
BALANCE SHEET
1.19 B ASSETS
-8.45%
Growth Rates
1Year -8.45%
3Years -2.74%
5Years 28.93%
7Years 17.89%
10Years 60.21%
319 M LIABILITIES
27.21%
Growth Rates
1Year 27.21%
3Years 7.87%
5Years 37.72%
7Years 22.83%
10Years 58.80%
872 M EQUITY
-16.97%
Growth Rates
1Year -16.97%
3Years -5.71%
5Years 26.43%
7Years 16.43%
10Years 60.75%
BALANCE SHEET DECOMPOSITION
Balance Sheet Intellia Therapeutics, Inc.
image
Current Assets 640 M
Cash & Short-Term Investments 602 M
Receivables 8.52 M
Other Current Assets 29.8 M
Non-Current Assets 551 M
Long-Term Investments 44.3 M
PP&E 247 M
Other Non-Current Assets 260 M
50.50 %3.72 %20.71 %21.85 %Total Assets$1.2b
Current Liabilities 111 M
Accounts Payable 14.6 M
Short-Term Debt 20.2 M
Other Current Liabilities 76 M
Non-Current Liabilities 208 M
Long-Term Debt 0
Other Non-Current Liabilities 208 M
4.57 %6.35 %23.83 %65.26 %Total Liabilities$319.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 189.2 226.7 523.5 123.4 160.0 57.2 58.9 340.7 273.1 75.8 9.8
Short Term Investments 412.3 685.5 669.1 625.3 437.4 222.5 255.2 0 0 0 0
Receivables 8.5 36.5 3.8 2.0 2.1 4.6 7.5 10.5 6.5 1.0 0
Inventory 0 0 (69.3) (337.4) (19.1) 0 0 0 0 0 0
Other Current Assets 29.8 49.7 20.4 37.2 14.3 10.3 6.7 7.4 3.6 0.8 0.3
Total Current Assets 639.9 998.3 1 216.8 769.3 597.4 289.5 325.0 354.8 281.3 77.6 10.1
PP&E 246.7 148.1 161.0 100.1 55.1 37.1 17.1 15.3 10.6 2.7 0.3
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 44.3 154.5 142.3 425.1 1.9 4.7 0 0 0 0 0
Other Long Term Assets 260.2 0 0 0 22.0 2.9 5.3 6.1 7.0 1.8 0.3
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 191.0 1 301.0 1 520.1 1 294.5 676.3 334.3 347.3 376.2 299.0 82.1 10.7
LIABILITIES
Accounts Payable 14.6 7.5 5.2 9.7 10.5 3.9 2.7 2.2 4.7 1.4 0.2
Short Term Debt 20.2 32.4 16.7 18.2 11.4 11.5 0 0 0 0 0
Other Current Liabilities 55.4 67.0 60.9 34.2 19.9 7.5 10.7 8.0 5.9 2.8 2.2
Total Current Liabilities 110.9 115.2 126.6 125.8 64.3 35.6 40.6 31.4 30.7 10.7 2.4
Long Term Debt 0 96.7 114.0 64.9 33.6 12.6 0 0 0 0 0
Deferred Tax Income 0 0 0 (63.5) (51.4) (16.1) 0 0 0 0 0
Other Liabilities 0 0 24.0 0 0 0 13 K 0.2 0.3 0.3 0.8
Total Liabilities 319.1 250.8 284.5 254.2 149.2 64.4 69.4 75.6 89.1 14.8 3.1
EQUITY
Common Stock 10 K 9 K 9 K 7 K 7 K 5 K 5 K 4 K 4 K 3 K 0.7
Retained Earnings (2 177.4) (1 658.4) (1 177.2) (703.0) (435.1) (300.9) (201.0) (121.1) (53.6) (21.9) (9.5)
Other Accumulative Comprehensive Income/Loss 0.6 (2.3) (7.5) (2.6) 1 K 0.3 28 K 0 0 (88.6) (16.4)
Total Equity 872.0 1 050.2 1 235.6 1 040.2 527.1 269.9 277.9 300.6 209.8 67.4 7.6
Total Liabilities and Equity 1 191.0 1 301.0 1 520.1 1 294.5 676.3 334.3 347.3 376.2 299.0 82.1 10.7
SHARES OUTSTANDING
Common Shares Outstanding 98.8 88.8 77.0 70.9 56.0 47.2 43.1 36.0 22.2 17.7 0.5